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All in the Numbers
The C-C chemokine ligand 4-like 
(CCL4L) protein occurs with 
copy-number variation (CNV), 
and this CNV is associated with 
inflammatory diseases. Pedrosa 
and colleagues found that CCL4L 
polymorphisms are not involved 
in psoriasis susceptibility, 
although high CCL4L CNV was 
correlated with an elevated risk 
of severe psoriasis and lower 
CCL4L CNV was associated with 
milder disease. Importantly, 
CCL4L alleles and their protein 
levels in serum correlate with 
psoriasis course, with the 
CCL4L1 allele occurring more 
frequently in patients with 
severe psoriasis and the CCL4L2 
allele occurring more frequently 
in those with milder disease.  
See page 1830
Understanding  
the Treatment
Because the molecular 
mechanism of action of the 
first-line melanoma treatment 
dacarbazine (DTIC) is not 
known, Nardin and colleagues 
used global transcriptome 
analysis combined with 
immunohistochemistry to 
identify DTIC treatment–induced 
modifications in gene expression. 
Genes encoding stromal 
remodeling and lymphocyte 
infiltration components were the 
predominant targets upregulated 
in lesions sensitive to the 
chemotherapy. These alterations 
were associated with improved 
patient survival, offering a 
jumping-off point to develop 
personalized therapies for 
this disease, which is currently 
marked by a mere 10–15% 
clinical response to standard 
chemotherapeutic regimes.  
See page 1896
UVB Resolution
Although UVB (300–315 nm) phototherapy results in 
quite effective clearance and remission of psoriatic 
plaques, the underlying mechanism of action of this 
treatment is not known. Weatherhead and colleagues 
compared a clinically effective wavelength (311 nm) 
with a known ineffective wavelength (290 nm) and 
discovered keratinocyte apoptosis in lesional skin. 
Furthermore, development of a computation model 
confirmed that this rate of apoptosis was sufficient to 
explain the UVB-induced plaque resolution, indicat-
ing that keratinocyte apoptosis is a key mechanism in 
psoriatic plaque clearance. See page 1916
Conversion of the Tregs
In an effort to understand the 
mechanisms underlying chron-
ic autoimmune inflammation, 
Bovenschen and colleagues 
examined the function of regu-
latory T cells (Tregs) in patients 
with psoriasis. Peripheral blood–
derived Tregs from patients with 
severe psoriasis differentiate into a 
T helper type 17–associated phe-
notype via promotion by IL-23. 
This increased differentiation in 
patients with severe psoriasis was 
associated with high expression of 
the retinoic acid–related orphan 
receptor-γt and with enhanced loss 
of the Treg master transcription factor Foxp3. Furthermore, Foxp3+ IL-17A-producing 
cells were found in lesional skin of these patients, linking these cells with perpetuation 
of the immune pathology associated with psoriasis. See page 1853
Deleterious Difference
Previously, mutations in keratin 5 (K5) and 
K14 have been found to underlie epidermo-
lysis bullosa simplex (EBS). Natsuga and col-
leagues identified a new missense mutation 
(Ala413Pro) in KRT14, the gene that encodes 
K14, in a proband with localized EBS. 
Interestingly, a different nucleotide substitution 
at the same position (Ala413Thr) was identi-
fied in normal controls. Molecular dynamic 
modeling and cell culture assays revealed 
that proline replacement at this position is pathogenic, whereas threonine replacement 
results in healthy skin. This study demonstrates that different amino acid substitutions at 
one position can produce different biological effects. See page 1869
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